Chemours' Earnings Outpace Estimates, Revenues Miss in Q4

Core Insights - The Chemours Company reported a net loss of $8 million or 5 cents per share for Q4 2024, an improvement from a loss of$18 million or 12 cents in the same quarter last year [1] - Adjusted earnings came in at 11 cents per share, beating the Zacks Consensus Estimate of 10 cents [1] - Fourth-quarter net sales were $1,359 million, reflecting a 1$1,359.8 million [2] Financial Performance - Adjusted EBITDA rose 2% year-over-year to 179 million, driven by cost savings from the Titanium Technologies Transformation Plan and increased volumes in Thermal & Specialized Solutions [3] - For FY 2024, net sales totaled 5,782 million, a decline of 4.9% from the previous year, with adjusted net income dropping to $182 million from$425 million [7] - Cash provided by operating activities in Q4 2024 was $138 million, down from$482 million in the prior-year quarter [8] Segment Performance - The Titanium Technologies division reported revenues of $632 million, a 3$390 million, driven by a 7% increase in volume, although it fell short of estimates [5] - Advanced Performance Materials revenues amounted to $324 million, a decline of approximately 1$825 million and $975 million, with capital expenditures projected between$250 million and $300 million [10] Stock Performance - Chemours shares have decreased by 39.7% over the past year, contrasting with a 0.8% decline in the industry [11]